CLASS III Drug recall · Reported 8 May 2013 · FDA Enforcement Report

Femhrt (norethindrone acetate recalled by Warner Chilcott Company

Warner Chilcott is recalling Femhrt (norethindrone acetate and ethinyl estradiol) tablets, 1.0 mg/5.0 mcg bottle (, distributed nationwide in the US. The recall was initiated on 15 Feb 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot# 507694B; exp 02/13
Quantity recalled6,408 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-305-2013
FDA event ID
64459
Recalling firm
Warner Chilcott, Fajardo, PR
Classification
Class III
Status
Terminated
Recall initiated
15 Feb 2013
FDA classified
30 Apr 2013
Reported
8 May 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

15 Feb 2013Recall initiated by company
30 Apr 2013Classified by FDA+74 days
8 May 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Femhrt (norethindrone acetate and ethinyl estradiol) tablets, 1.0 mg/5.0 mcg, 90 count bottle ( NDC#: 0430-0544-23), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Marketed by Warner Cholcott (US), LLC, Rockaway, NJ 07866

Where it was distributed

US Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

Which lots are affected?

Lot# 507694B; exp 02/13

Where was it sold?

US Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 64459

More recalls from Warner Chilcott

All 5

Other Femhrt (norethindrone recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIFemhrt (norethindrone acetate recalled by Warner Chilcott CompanyWarner ChilcottPackaging DefectsNationwide